Story

On air. The free wire runs 15 minutes behind live. See pricing

World, crypto, finance and tech news, scored for impact.

MarketsSEC EDGAR SCHEDULE 13GFiled 2 days ago

Whitehawk Therapeutics, Inc.: Coastlands Capital LP amends Schedule 13G stake filing

Open the sourceReported by SEC EDGAR SCHEDULE 13G, sec.gov, 14 November 2026, by SEC EDGAR SCHEDULE 13G

Not investment advice. Muhabbit scores how much a story may matter, not which way to trade.

Coastlands Capital LP amended its Schedule 13G filing on Whitehawk Therapeutics, Inc., updating its beneficial ownership stake with the SEC under accession number 0001104659-26-127421. The filing, submitted via EDGAR, reflects a change to the investor's previously reported position in the clinical-stage biotech. Schedule 13G amendments are typically triggered when passive investors cross or adjust threshold ownership levels, making the update a signal of shifting institutional interest in the company. The specific revised share count and percentage were not detailed in the headline disclosure. Investors will watch for further 13G or 13D filings to gauge whether Coastlands is building or trimming its position, and for any corresponding movement in Whitehawk's shares.

Muhabbit's AI wrote this summary in its own words from SEC EDGAR SCHEDULE 13G's report. It can get details wrong, so check the source.

Named in this story

Coastlands Capital LP, Whitehawk Therapeutics, Inc.